IPP Bureau
Roquette, Beren Therapeutics join forces to advance cyclodextrin technologies
By IPP Bureau - May 29, 2023
Aim of the agreement is to expand the full potential of Beren’s cyclodextrin technologies and their medicinal applications.
Eugia Pharma receives USFDA approval for Carboprost Tromethamine Injection
By IPP Bureau - May 27, 2023
The product is expected to be launched in June 2023
Sun Pharmaceutical Industries posts Q4 FY23 consolidated PAT at Rs. 2016.78 Cr
By IPP Bureau - May 27, 2023
The company has reported total income of Rs. 11303.95 crores during the period ended March 31, 2023
Health Minister Mandaviya inaugurates 8th International Conference on Pharma and Medical Device Sector
By IPP Bureau - May 27, 2023
Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
Labindia partners with Hamilton Laboratory to launch ‘Labindia Hamilton’
By IPP Bureau - May 27, 2023
Product deliveries scheduled in Q3 of 2023
Aster DM Healthcare reports Q4 FY23 consolidated profit at Rs. 170.77 Cr
By IPP Bureau - May 26, 2023
The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023
GMM Pfaudler Q4 FY23 Consolidated PAT jumps to Rs. 38.47 Cr
By IPP Bureau - May 26, 2023
The company has reported total income of Rs. 880.59 crores during the period ended March 31, 2023
Ministry of Minority Affairs supports development of unani medicine system
By IPP Bureau - May 26, 2023
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
Lupin Diagnostics Launches Satellite Laboratory in Vijayawada
By IPP Bureau - May 26, 2023
Continues to Expand its Presence in South India
Lincoln Pharmaceuticals posts FY23 PAT at Rs. 72.90 Cr
By IPP Bureau - May 26, 2023
For Q4 ended FY23, company reported net profit of Rs. 12.56 crore as against net profit of Rs. 11.02 crore in the corresponding period last year
Mandaviya addresses 76th World Health Assembly
By IPP Bureau - May 25, 2023
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr
By IPP Bureau - May 25, 2023
The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023
JB Pharma records revenue growth of 22% to Rs. 762 Cr
By IPP Bureau - May 25, 2023
Operating EBITDA increased by 21% to INR 181 crores in Q4 FY23
GenWorks launches FenomPro breath analyser
By IPP Bureau - May 25, 2023
Ensures efficient testing of FeNO as it is a simple tool for the diagnosis, screening & monitoring of Asthma patients
